 |
PDBsum entry 2w2d
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hydrolase
|
 |
|
Title:
|
 |
Crystal structure of a catalytically active, non-toxic endopeptidase derivative of clostridium botulinum toxin a
|
|
Structure:
|
 |
Botulinum neurotoxin a light chain. Chain: a, c. Fragment: residues 1-442. Synonym: bontoxilysin-a. Engineered: yes. Botulinum neurotoxin a heavy chain. Chain: b, d. Fragment: residues 447-877. Synonym: bontoxilysin-a.
|
|
Source:
|
 |
Clostridium botulinum. Organism_taxid: 1491. Expressed in: escherichia coli. Expression_system_taxid: 511693.
|
|
Resolution:
|
 |
|
2.59Å
|
R-factor:
|
0.212
|
R-free:
|
0.253
|
|
|
Authors:
|
 |
G.Masuyer,N.Thiyagarajan,P.L.James,P.M.H.Marks,J.A.Chaddock, K.R.Acharya
|
|
Key ref:
|
 |
G.Masuyer
et al.
(2009).
Crystal structure of a catalytically active, non-toxic endopeptidase derivative of Clostridium botulinum toxin A.
Biochem Biophys Res Commun,
381,
50-53.
PubMed id:
|
 |
|
Date:
|
 |
|
29-Oct-08
|
Release date:
|
24-Mar-09
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
Chains A, B, C, D:
E.C.3.4.24.69
- bontoxilysin.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Limited hydrolysis of proteins of the neuroexocytosis apparatus, synaptobrevins, SNAP25 or syntaxin. No detected action on small molecule substrates.
|
 |
 |
 |
 |
 |
Cofactor:
|
 |
Zn(2+)
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
Biochem Biophys Res Commun
381:50-53
(2009)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure of a catalytically active, non-toxic endopeptidase derivative of Clostridium botulinum toxin A.
|
|
G.Masuyer,
N.Thiyagarajan,
P.L.James,
P.M.Marks,
J.A.Chaddock,
K.R.Acharya.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Botulinum neurotoxins (BoNTs) modulate cholinergic nerve terminals to result in
neurotransmitter blockade. BoNTs consists of catalytic (LC), translocation (Hn)
and cell-binding domains (Hc). The binding function of the Hc domain is
essential for BoNTs to bind the neuronal cell membrane, therefore, removal of
the Hc domain results in a product that retains the endopeptidase activity of
the LC but is non-toxic. Thus, a molecule consisting of LC and Hn domains of
BoNTs, termed LHn, is a suitable molecule for engineering novel therapeutics.
The structure of LHA at 2.6 A reported here provides an understanding of the
structural implications and challenges of engineering therapeutic molecules that
combine functional properties of LHn of BoNTs with specific ligand partners to
target different cell types.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
G.Masuyer,
M.Beard,
V.A.Cadd,
J.A.Chaddock,
and
K.R.Acharya
(2011).
Structure and activity of a functional derivative of Clostridium botulinum neurotoxin B.
|
| |
J Struct Biol,
174,
52-57.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.Montal
(2010).
Botulinum neurotoxin: a marvel of protein design.
|
| |
Annu Rev Biochem,
79,
591-617.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |
|